Document Detail


Vincristine-induced peripheral neuropathy in a neonate with congenital acute lymphoblastic leukemia.
MedLine Citation:
PMID:  20216233     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We report the case of a 46-day-old boy with a fulminant vincristine-induced peripheral neuropathy after treatment for congenital acute lymphoblastic leukemia. Flaccid paralysis developed at the end of the first phase of induction, requiring intubation and ventilation for 51 days. Treatment was initiated with levocarnitine, N-acetylcysteine, and pyridoxine and progressive reversal of the neuropathy occurred over the next 4 months. Potential differences in pathogenesis and presentation of vincristine neurotoxicity and Guillian-Barre syndrome in the neonate are discussed.
Authors:
Steven K Baker; David M Lipson
Related Documents :
19332933 - Transient leukemia.
272863 - Acute lymphoblastic leukemia. its occurrence with hypereosinophilic syndrome' and bilat...
7835183 - Tear mucus ferning in patients with sjögren's syndrome.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Journal of pediatric hematology/oncology     Volume:  32     ISSN:  1536-3678     ISO Abbreviation:  J. Pediatr. Hematol. Oncol.     Publication Date:  2010 Apr 
Date Detail:
Created Date:  2010-04-08     Completed Date:  2010-05-06     Revised Date:  2011-10-06    
Medline Journal Info:
Nlm Unique ID:  9505928     Medline TA:  J Pediatr Hematol Oncol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  e114-7     Citation Subset:  IM    
Affiliation:
Department of Medicine, Physical Medicine & Neurology, Neuromuscular Disease Clinic, McMaster University Medical Centre, McMaster University, Hamilton, Ontario, Canada. bakersk@mcmaster.ca
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acetylcysteine / therapeutic use
Antineoplastic Agents, Phytogenic / adverse effects*
Carnitine / therapeutic use
Drug Therapy, Combination
Free Radical Scavengers / therapeutic use
Humans
Infant
Male
Peripheral Nervous System Diseases / chemically induced*,  drug therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma / congenital*,  drug therapy*
Pyridoxine / therapeutic use
Vincristine / adverse effects*
Vitamin B Complex / therapeutic use
Chemical
Reg. No./Substance:
0/Antineoplastic Agents, Phytogenic; 0/Free Radical Scavengers; 12001-76-2/Vitamin B Complex; 541-15-1/Carnitine; 57-22-7/Vincristine; 616-91-1/Acetylcysteine; 65-23-6/Pyridoxine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Thyroid papillary carcinoma in a 3-year-old American boy with a family history of thyroid cancer: a ...
Next Document:  Fatal neurotoxicity in a patient with down syndrome treated with chemotherapy, irradiation, stem cel...